- Home
- RBKB vs CNTB Comparison
RBKB vs CNTB Comparison
Compare RBKB & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RBKB | CNTB |
|---|---|---|
| Founded | 1860 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.1M | 157.1M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RBKB | CNTB |
|---|---|---|
| Price | $10.86 | $2.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 7.3K | ★ 633.0K |
| Earning Date | 10-28-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $45,306,000.00 | $762,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $453,067.90 |
| P/E Ratio | $24.17 | ★ N/A |
| Revenue Growth | ★ 54.93 | N/A |
| 52 Week Low | $9.31 | $0.51 |
| 52 Week High | $13.99 | $3.28 |
Technical Indicators
Market Signals| Indicator | RBKB | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 61.03 | 62.02 |
| Support Level | $10.32 | $2.52 |
| Resistance Level | $11.12 | $2.87 |
| Average True Range (ATR) | 0.30 | 0.36 |
| MACD | 0.19 | 0.02 |
| Stochastic Oscillator | 83.85 | 65.36 |
Price Performance
Historical ComparisonAbout RBKB Rhinebeck Bancorp Inc.
Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank which provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management (RAM). The Bank's primary business activity is accepting deposits from the general public and using those funds to originate indirect automobile loans (automobile loans referred by automobile dealerships), commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and one-to four-family residential real estate loans, and to purchase investment securities.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.